Thymic myoid cells as a source of cells for myoblast transfer.
Transplantation of disaggregated myoblasts from normal donor to the muscles of a diseased host, or reimplantation of genetically modified host myoblasts, has been suggested as a possible route to therapy for inherited myopathies such as Duchenne muscular dystrophy, or to supply missing proteins that are required systemically in diseases such as hemophilia. With two exceptions, studies of myoblast transfer in the mouse have involved transplantation of donor myoblasts isolated from adult or neonatal skeletal muscle satellite cells. In this study we present evidence that thymic myoid cells are capable of participating in the regeneration of postnatal skeletal muscle, resulting in the expression of donor-derived proteins such as dystrophin and retrovirally encoded proteins such as beta-galactosidase within host muscles. This leads us to conclude that thymic myoid cells may provide an alternative to myoblasts derived from skeletal muscle as a source of myogenic cells for myoblast transfer.
Pagel
C N
CN
MRC Clinical Sciences Centre, Imperial College School of Medicine, Hammersmith Hospital, London, UK.
Morgan
J E
JE
Gross
J G
JG
Partridge
T A
TA
D000818:Animals; D002454:Cell Differentiation; D002460:Cell Line; D017690:Cell Transplantation; D016189:Dystrophin / Q000032:analysis / Q000235:genetics; D018014:Gene Transfer Techniques; D017930:Genes, Reporter; D015316:Genetic Therapy; D051379:Mice; D018101:Mice, Inbred mdx; D008822:Mice, Transgenic; D024510:Muscle Development; D018482:Muscle, Skeletal / Q000033:anatomy & histology / Q000254:growth & development / Q000378:metabolism* / Q000528:radiation effects; D013950:Thymus Gland / Q000166:cytology* / Q000254:growth & development / Q000502:physiology / Q000637:transplantation*; D001616:beta-Galactosidase / Q000235:genetics / Q000378:metabolism
D016189:Dystrophin; D001616:beta-Galactosidase